{"entity":{"type":"insider","cik":"0001607737","url":"/insider/0001607737","json_url":"/insider/0001607737.json","name":"GALA RENEE D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":6,"first":"2015-08-17","last":"2023-05-19","span_basis":"filed_date"},"name_variants":[{"name":"GALA RENEE D","source":"filing","n_filings":6,"first_seen":"2015-08-17","last_seen":"2023-05-19"}],"transactions":[{"id":8307354,"accession":"0001765581-23-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-23-000042","line_url":"/filing/0001765581-23-000042#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":131.7457,"price_display":"131.75","price_state":"stated","total_value":790474.2,"total_display":"790,474.20","total_whole":"790,474","shares_owned_after":35978.0,"shares_owned_after_display":"35,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":6764886,"accession":"0001765581-22-000143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-22-000143","line_url":"/filing/0001765581-22-000143#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2635.0,"shares_display":"2,635","price_per_share":160.0,"price_display":"160.00","price_state":"stated","total_value":421600.0,"total_display":"421,600.00","total_whole":"421,600","shares_owned_after":32558.0,"shares_owned_after_display":"32,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":5986277,"accession":"0001179110-18-010637","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-18-010637","line_url":"/filing/0001179110-18-010637","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41539.0,"shares_display":"41,539","price_per_share":26.737647601049616,"price_display":"26.74","price_state":"stated","total_value":1110655.1437,"total_display":"1,110,655.14","total_whole":"1,110,655","shares_owned_after":172749.0,"shares_owned_after_display":"172,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-16","scope":"insider","n_lines":2},{"id":5986272,"accession":"0001179110-18-010637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-010637","line_url":"/filing/0001179110-18-010637#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2204.0,"shares_display":"2,204","price_per_share":27.7386,"price_display":"27.74","price_state":"stated","total_value":61135.8744,"total_display":"61,135.87","total_whole":"61,136","shares_owned_after":212588.0,"shares_owned_after_display":"212,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-16","scope":"insider"},{"id":6490795,"accession":"0001179110-18-007370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-007370","line_url":"/filing/0001179110-18-007370#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.2877,"price_display":"24.29","price_state":"stated","total_value":242877.0,"total_display":"242,877.00","total_whole":"242,877","shares_owned_after":236022.0,"shares_owned_after_display":"236,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-22","scope":"insider"},{"id":6677719,"accession":"0000899243-18-006756","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-006756","line_url":"/filing/0000899243-18-006756#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":15.5335,"price_display":"15.53","price_state":"stated","total_value":139801.5,"total_display":"139,801.50","total_whole":"139,802","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-07","filed_date":"2018-03-07","scope":"insider"},{"id":6677715,"accession":"0000899243-18-006756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-006756","line_url":"/filing/0000899243-18-006756#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":15300.0,"total_display":"15,300.00","total_whole":"15,300","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-07","scope":"insider"},{"id":8152438,"accession":"0001179110-15-012247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-012247","line_url":"/filing/0001179110-15-012247#line-2","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":12.16,"price_display":"12.16","price_state":"stated","total_value":60800.0,"total_display":"60,800.00","total_whole":"60,800","shares_owned_after":161177.0,"shares_owned_after_display":"161,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-17","scope":"insider"},{"id":8152427,"accession":"0001179110-15-012247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-012247","line_url":"/filing/0001179110-15-012247#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001607737","owner_name":"GALA RENEE D","owner_display_name":"GALA RENEE D","owner_url":"/insider/0001607737","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":12.19,"price_display":"12.19","price_state":"stated","total_value":60950.0,"total_display":"60,950.00","total_whole":"60,950","shares_owned_after":154279.0,"shares_owned_after_display":"154,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-13","filed_date":"2015-08-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"Jazz Pharmaceuticals plc","url":"/issuer/0001232524","role":"Officer (EVP & Chief Financial Officer)","n_filings":2,"first_seen":"2022-12-22","last_seen":"2023-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001583107","name":"Theravance Biopharma, Inc.","url":"/issuer/0001583107","role":"Officer (SVP, Chief Financial Officer)","n_filings":3,"first_seen":"2015-08-17","last_seen":"2018-08-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001088856","name":"CORCEPT THERAPEUTICS INC","url":"/issuer/0001088856","role":"Director","n_filings":1,"first_seen":"2018-03-07","last_seen":"2018-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001607737","retrieved_at":"2026-08-25T05:51:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}